Joseph Ross, MD, MHS
Professor of Medicine (General Medicine) and of Public Health (Health Policy and Management)Cards
Contact Info
General Internal Medicine
P.O. Box 208093
New Haven, CT 06520-8093
United States
Education
Yale School of Medicine (2006)
Albert Einstein College of Medicine (2001)
University of Rochester (1996)
Training
Montefiore Medical Center (2004)
Contact Info
General Internal Medicine
P.O. Box 208093
New Haven, CT 06520-8093
United States
Education
Yale School of Medicine (2006)
Albert Einstein College of Medicine (2001)
University of Rochester (1996)
Training
Montefiore Medical Center (2004)
Contact Info
General Internal Medicine
P.O. Box 208093
New Haven, CT 06520-8093
United States
Education
Yale School of Medicine (2006)
Albert Einstein College of Medicine (2001)
University of Rochester (1996)
Training
Montefiore Medical Center (2004)
About
Copy Link
Titles
Professor of Medicine (General Medicine) and of Public Health (Health Policy and Management)
Biography
Joseph S. Ross, MD, MHS, is a Professor of Medicine (General Medicine) and of Public Health (Health Policy and Management), a member of the Center for Outcomes Research and Evaluation (CORE) at the Yale-New Haven Hospital, and an Co-Director of the National Clinician Scholars program (NCSP) at Yale. He completed his undergraduate degrees in biological science: neuroscience and psychology at the University of Rochester and his medical degree at the Albert Einstein College of Medicine, Bronx, NY. After completing his post-graduate training in primary care internal medicine at Montefiore Medical Center in Bronx, NY, Dr. Ross was a fellow in the Robert Wood Johnson Foundation Clinical Scholars program at Yale, earning a Master’s degree in health sciences research. Using health services research methods, Dr. Ross’s research focuses on examining factors which affect the use or delivery of recommended ambulatory care services for older adults and other vulnerable populations, evaluating the impact of state and federal policies on the delivery of appropriate and higher quality care, and addressing issues related to pharmaceutical and medical device regulation, evidence development, postmarket surveillance, and clinical adoption. In addition, he collaborates with a multi-disciplinary team of investigators under contract for the Centers for Medicare and Medicaid Services to develop statistical models that are used to measure and publicly report hospital and ambulatory care clinical outcomes using administrative data. Dr. Ross co-directs the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI), the Yale Open Data Access (YODA) Project, the Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT) at Yale Law School, and leads efforts at Yale-New Haven Health System in collaboration with the National Evaluation System for health Technology. Dr. Ross is currently a Deputy Editor at JAMA, co-founder of medRxiv, Chair of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC), and a member of the New England Comparative Effectiveness Public Advisory Council (New England CEPAC) for ICER.
Appointments
General Internal Medicine
ProfessorPrimaryHealth Policy & Management
ProfessorSecondaryInstitution for Social and Policy Studies
ProfessorSecondary
Other Departments & Organizations
- Cancer Prevention and Control
- Center for Outcomes Research & Evaluation (CORE)
- Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT)
- General Internal Medicine
- Health Policy & Management
- Institution for Social and Policy Studies
- Internal Medicine
- National Clinician Scholars Program
- Regulatory Affairs Track
- Yale School of Public Health
- Yale Ventures
Education & Training
- MHS
- Yale School of Medicine (2006)
- Postgraduate Training
- Montefiore Medical Center (2004)
- MD
- Albert Einstein College of Medicine (2001)
- BS
- University of Rochester (1996)
- BA
- University of Rochester (1996)
Research
Copy Link
Overview
Medical Research Interests
Public Health Interests
ORCID
0000-0002-9218-3320
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Harlan Krumholz, MD, SM
Reshma Ramachandran, MD, MPP, MHS
Jeph Herrin, PhD
Jennifer E Miller, PhD
Cary P Gross, MD
Jeptha Curtis, MD
Quality of Health Care
Delivery of Health Care
Health Services Research
Publications
2025
Costs and benefits of early access to new cancer drugs through the US Food and Drug Administration’s accelerated approval pathway: retrospective observational study and economic evaluation
Naci H, Shahzad M, Murphy P, Zhang Y, Costa R, Ross J, Wagner A. Costs and benefits of early access to new cancer drugs through the US Food and Drug Administration’s accelerated approval pathway: retrospective observational study and economic evaluation. BMJ Medicine 2025, 4: e001934. PMID: 41431468, PMCID: PMC12718571, DOI: 10.1136/bmjmed-2025-001934.Peer-Reviewed Original ResearchAltmetricConceptsFood and Drug AdministrationCancer drug indicationsOverall survival benefitLife-year gainsSurvival benefitCancer drugsRegular approvalSurvival benefit to patientsLife yearsDrug AdministrationDrug indicationsUS Food and Drug AdministrationRetrospective observational studyBenefits to patientsApproval pathwayBreast cancer indicationsMedicare spendingClinical efficacyYear gainSurvival gainCancer indicationsEarly accessPrimary outcomeObservational studyMedicare beneficiariesPostmarket Drug Safety−Related Actions Before and After the US Food and Drug Administration Amendments Act
Doernberg H, Wallach J, Jeffery M, Mooghali M, Ramachandran R, Ross J. Postmarket Drug Safety−Related Actions Before and After the US Food and Drug Administration Amendments Act. JAMA Internal Medicine 2025, 186 PMID: 41359349, PMCID: PMC12687201, DOI: 10.1001/jamainternmed.2025.6566.Peer-Reviewed Original ResearchAltmetricEnhancing FDA Drug-Safety Surveillance — Beyond Releasing Daily Adverse-Event Data
Wallach J, Ross J, Ramachandran R. Enhancing FDA Drug-Safety Surveillance — Beyond Releasing Daily Adverse-Event Data. The New England Journal Of Medicine 2025, 393: 2284-2286. PMID: 41358589, DOI: 10.1056/nejmp2513460.Peer-Reviewed Original ResearchAltmetricState Policies and Facility Practices of IV Hydration Spas in the US
Sivakumar A, Forman H, Wang I, Lurie P, Ross J. State Policies and Facility Practices of IV Hydration Spas in the US. JAMA Internal Medicine 2025, 185: 1455-1461. PMID: 41051745, PMCID: PMC12501857, DOI: 10.1001/jamainternmed.2025.5028.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsCross-sectional content analysisDistrict of ColumbiaFacility practicesWebsite reviewDispensing practicesState-level policiesLicensed health professionalsLicensed medical professionalsShopper studyProduct claimsMixed-methods studyState policyProduct offeringsHealth professionalsMain OutcomesInsurance coverageMedical professionalsFacility websitesWaiver requirementsPublic healthRegulatory lawsStaffingCompounding practicesHealth claimsUS statesClinical Characteristics of Adults at Risk of Medicaid Disenrollment Due to HR 1 Work Requirements
Chetty A, Ross J, Chen A. Clinical Characteristics of Adults at Risk of Medicaid Disenrollment Due to HR 1 Work Requirements. JAMA: The Journal Of The American Medical Association 2025, 334: 1850-1853. PMID: 41032309, PMCID: PMC12489788, DOI: 10.1001/jama.2025.16533.Peer-Reviewed Original ResearchCitationsAltmetricPayments to Health Care Professionals and Teaching Hospitals by AI- and Machine Learning–Enabled Medical Device Manufacturers
Nguyen D, Murayama A, Li T, Cheruvathur J, Freeman L, Wallis C, Rosella L, Kulkarni G, Kanter G, Marshall D, Ross J, Detsky A. Payments to Health Care Professionals and Teaching Hospitals by AI- and Machine Learning–Enabled Medical Device Manufacturers. JAMA: The Journal Of The American Medical Association 2025, 334: 1669-1672. PMID: 40982240, PMCID: PMC12455483, DOI: 10.1001/jama.2025.14813.Peer-Reviewed Original ResearchAltmetricHospital Acquisition Costs for Breakthrough-Designated Devices Awarded Supplemental Medicare Reimbursement
Moneer O, Kadakia K, Dhruva S, Ross J, Roth L, Burke J, Rathi V. Hospital Acquisition Costs for Breakthrough-Designated Devices Awarded Supplemental Medicare Reimbursement. JAMA Health Forum 2025, 6: e255183. PMID: 41296375, PMCID: PMC12658659, DOI: 10.1001/jamahealthforum.2025.5183.Peer-Reviewed Original ResearchAltmetricSemaglutide and Tirzepatide Prescribing for Obesity in Patients With Preexisting Comorbid Cancers
Kim C, Dinan M, Robinson T, Ross J, Jastreboff A, Krumholz H, Lu Y. Semaglutide and Tirzepatide Prescribing for Obesity in Patients With Preexisting Comorbid Cancers. JAMA Oncology 2025, 12 PMID: 41196576, PMCID: PMC12593664, DOI: 10.1001/jamaoncol.2025.4560.Peer-Reviewed Original ResearchAltmetricGlobal Rounds: United States
Khan M, Rashid A, Ross J. Global Rounds: United States. Circulation 2025, 152: 1265-1267. PMID: 41183162, DOI: 10.1161/circulationaha.125.074990.Peer-Reviewed Original ResearchToward a Safer World by 2040
Rivara F, Richmond T, Hargarten S, Branas C, Rowhani-Rahbar A, Webster D, Richardson J, Ayanian J, Boggan D, Braga A, Buggs S, Cerdá M, Chen F, Chitkara A, Christakis D, Crifasi C, Dawson L, deRoon-Cassini T, Dicker R, Erete S, Galea S, Hemenway D, La Vigne N, Levine A, Ludwig J, Maani N, McCarthy R, Patton D, Quick J, Ranney M, Rimanyi E, Ross J, Sakran J, Sampson R, Song Z, Tucker J, Ulrich M, Vargas L, Wilcox R, Wilson N, Zimmerman M, Cavataro B, Diez Roux A, Lowy J, South E, Whitehead W. Toward a Safer World by 2040. JAMA: The Journal Of The American Medical Association 2025, 334: 2208-2219. PMID: 41182880, DOI: 10.1001/jama.2025.18076.Peer-Reviewed Original ResearchCitationsAltmetricConceptsFirearm violenceConstitutional protectionFirearm deathsViolence interventionsFirearm ownershipFirearmFirearm injuriesViolencePrimordial preventionHarmCollective responseEthical considerationsWhole-society approachEvidence-based strategiesTechnological strengthSocietyTechnological innovationCommunityVision centersCountriesSummitSafer WorldSuicideProtectionFundamental structure
Academic Achievements & Community Involvement
Copy Link
Activities
activity JAMA
06/01/2023 - PresentJournal ServiceDeputy Editoractivity BMJ
2020 - 2023Journal ServiceAssociate Editoractivity JAMA Internal Medicine
04/01/2013 - 12/31/2019Journal ServiceAssociate Editoractivity Journal of General Internal Medicine
2011 - 2013Journal ServiceDeputy Editor
News
Copy Link
News
- November 03, 2025Source: JAMA
Dean Megan Ranney contributes to new report aimed at reducing firearm violence
- October 21, 2025Source: Yale News
IV Hydration Spas Lack Adequate Oversight, Study Finds
- September 18, 2025Source: U.S. News & World Report
Pharma Payments Might Influence MS Drug Prescriptions, Researchers Argue
- September 16, 2025
Fellow Focus in Four: Joshua Skydel, MD, Rheumatology, Allergy, and Immunology
Get In Touch
Copy Link
Contacts
General Internal Medicine
P.O. Box 208093
New Haven, CT 06520-8093
United States
Locations
E.S. Harkness Memorial Hall, Building A
Academic Office
367 Cedar Street, Ste 405B
New Haven, CT 06510